Advanced search
Publication Cover
mAbs Volume 13, 2021 - Issue 1
Submit an article Journal homepage
2,302
Views
4
CrossRef citations to date
0
Altmetric
Report

Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX

Anne E.G. Lenferinka Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9825-281XView further author information
ORCID Icon,
Paul C. McDonaldb Department of Integrative Oncology, Bc Cancer Research Institute, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-7238-2912View further author information
ORCID Icon,
Christiane Cantina Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Suzanne Grothéa Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Mylene Gosselina Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Jason Baardsnesa Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaORCID Iconhttps://orcid.org/0000-0001-5587-3034View further author information
ORCID Icon,
Myriam Banvillea Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Paul Lachancea Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Alma Roberta Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Yuneivy Cepero-Donatesa Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Stevo Radinovica Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Patrick Saloisa Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Marie Parata Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaORCID Iconhttps://orcid.org/0000-0003-4835-4345View further author information
ORCID Icon,
Hafida Oamaria Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Annie Duludea Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Mehul Patela Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Martin Lafrancea Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Andrea Acela Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Nathalie Bousquet-Gagnona Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Denis L’Abbéa Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Alex Pelletiera Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Félix Malenfanta Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Maria Jaramilloa Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaORCID Iconhttps://orcid.org/0000-0002-2416-9009View further author information
ORCID Icon,
Maureen O’Connor-Mccourta Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Cunle Wua Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Yves Durochera Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaORCID Iconhttps://orcid.org/0000-0002-2268-4111View further author information
ORCID Icon,
Mélanie Duchesnea Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Christine Gadourya Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Anne Marcila Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Yves Fortina Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Beatrice Paul-Roca Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Maurizio Acchionea Human Health Therapeutics Research Center, National Research Council of Canada, Montréal, CanadaView further author information
,
Shawn C. Chafeb Department of Integrative Oncology, Bc Cancer Research Institute, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0001-8802-651XView further author information
ORCID Icon,
Oksana Nemirovskyb Department of Integrative Oncology, Bc Cancer Research Institute, Vancouver, CanadaView further author information
,
Joseph Lauc Department of Molecular Oncology, Bc Cancer Research Institute, Vancouver, CanadaView further author information
,
Francois Bénardc Department of Molecular Oncology, Bc Cancer Research Institute, Vancouver, CanadaView further author information
&
Shoukat Dedharb Department of Integrative Oncology, Bc Cancer Research Institute, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0003-4355-1657View further author information
ORCID Icon show all
Article: 1999194 | Received 08 Jul 2021, Accepted 25 Oct 2021, Published online: 21 Nov 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Feng Ni, Cunle Wu, Ping Xu, Ping Wang, Yves Fortin, Melanie Arbour, Luke Masson, Denis L’Abbé, Andrea Acel, Mylene Gosselin & Anne E.G. Lenferink. (2023) Unique epitope–antibody interactions in the intrinsically disordered proteoglycan-like domain of human carbonic anhydrase IX defined by high-resolution NMR combined with yeast surface display. mAbs 15:1.
Read now
Claudiu T Supuran. (2023) Targeting carbonic anhydrases for the management of hypoxic metastatic tumors. Expert Opinion on Therapeutic Patents 0:0, pages 1-20.
Read now

Articles from other publishers (2)

Rui Mao, Wanqing Kong & Yukai He. (2022) The affinity of antigen-binding domain on the antitumor efficacy of CAR T cells: Moderate is better. Frontiers in Immunology 13.
Crossref
Paul C. McDonald, Shawn C. Chafe, Claudiu T. Supuran & Shoukat Dedhar. (2022) Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside. Cancers 14:14, pages 3297.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.